Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
Aurer, I., Jakšić, O., Bašić Kinda, S., Mrđenović, S., Ostojić Kolonić, S., Lozić, D. ... Valković, T. (2024). Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines, 12. (2). doi: 10.3390/biomedicines12020331
Aurer, Igor, et al. "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases." Biomedicines, vol. 12, no. 2, 2024. https://doi.org/10.3390/biomedicines12020331
Aurer, Igor, Ozren Jakšić, Sandra Bašić Kinda, Stefan Mrđenović, Slobodanka Ostojić Kolonić, Dominik Lozić, Hrvoje Holik, et al. "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases." Biomedicines 12, no. 2 (2024). https://doi.org/10.3390/biomedicines12020331
Aurer, I., et al. (2024) 'Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases', Biomedicines, 12(2). doi: 10.3390/biomedicines12020331
Aurer I, Jakšić O, Bašić Kinda S, Mrđenović S, Ostojić Kolonić S, Lozić D, and sur.. Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines [Internet]. 2024 January 31 [cited 2024 December 24];12(2). doi: 10.3390/biomedicines12020331
I. Aurer, et al., "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases", Biomedicines, vol. 12, no. 2, January 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:877674. [Accessed: 24 December 2024]